• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• BL Club
• Smartbuy

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai, Oct. 24

Growth in international markets like the US and Europe, besides an improved product mix helped Lupin post a healthy profit for the three months ended September 30, 2008, said the Managing Director, Dr Kamal Sharma.

Second quarter net profit rose to Rs 115 crore, from Rs 75 crore posted in the corresponding period last year. Net sales were up 36 percent at Rs 922 crore (Rs 675 crore).

International businesses account for 60 per cent of the company’s consolidated revenues and the US and Europe reported a growth of over 80 per cent, he told Business Line.

The company’s revenues in the international markets stood at Rs 545 crore, a rise of 65 per cent. The stage is poised for growth in the Europe and Japan, in future, he added. Lupin shares were down close to two per cent, at Rs 623 on the BSE.

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line